Alternate functions of physiological anticoagulants
Journal of Thrombosis and Haemostasis · 2025
DOI: 10.1016/j.jtha.2025.08.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Teagan Prouse und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Blood Coagulation, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: Novo Nordisk, Institute for Clinical and Translational Research, University of Maryland, Baltimore.
Abstract (Originalsprache)
The anticoagulant proteins antithrombin, protein C, protein S, and tissue factor pathway inhibitor are physiological regulators of the blood coagulation pathway and have complex roles in causing or modifying the severity of bleeding and clotting disorders. The anticoagulant activity, as well as alternative physiological functions, of these proteins also impact many other diseases beyond bleeding and clotting disorders. We searched PubMed for articles published between 2018 and early 2025 that pertained to alternative functions of these physiological anticoagulants in clinical disease and selected therapeutic applications in the following categories: cancer, cardiovascular disease, novel therapeutics, pregnancy health, inflammation and infection, blood-brain barrier protection, stroke, novel developments in thrombosis, and endothelial and platelet interactions. This review highlights recently identified physiological implications of antithrombin, protein C, protein S, and tissue factor pathway inhibitor functions that present an exciting therapeutic avenue for a diverse array of human diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
- Thrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, Wisconsin, USA.
- Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida, USA; Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
- Blood Transfusion Institute of Serbia, Hemostasis Department, Faculty of Medicine, University of Belgrade, Serbia.
- Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Hungary.
- Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA. Electronic address: rmajum@lsuhsc.edu.
Förderung
- Novo Nordisk
- Institute for Clinical and Translational Research, University of Maryland, Baltimore
Zitieren
APA
Prouse, T., Mast, A. E., Ignjatovic, V., Kovac, M., Bereczky, Z., & Majumder, R. (2025). Alternate functions of physiological anticoagulants. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.08.014
Vancouver
Prouse T, Mast AE, Ignjatovic V, Kovac M, Bereczky Z, Majumder R. Alternate functions of physiological anticoagulants. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.08.014
BibTeX
@article{Prouse2025,
author = {Prouse, Teagan and Mast, Alan E and Ignjatovic, Vera and Kovac, Mirjana and Bereczky, Zsuzsanna and Majumder, Rinku},
title = {Alternate functions of physiological anticoagulants},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
doi = {10.1016/j.jtha.2025.08.014}
}
EUVIMED